Pumen Technology announced that the company recently received 3 “People's Republic of China Medical Device Registration Certificates” issued by the Guangdong Drug Administration. The products include beta-collagen special sequence determination kit, plasminase-α2 fibrinase inhibitor complex determination kit, and tissue plasminogen activator-inhibitor 1 complex test kit, which are used for assisted diagnosis of osteoporosis, auxiliary diagnosis of thrombotic diseases, and auxiliary diagnosis of cardiovascular disease, respectively. As of the disclosure date of this announcement, the company and its holding subsidiaries have obtained 116 registration certificates for electrochemiluminescence supporting test reagents.

Pumen Technology announced that the company recently received 3 “People's Republic of China Medical Device Registration Certificates” issued by the Guangdong Drug Administration. The products include beta-collagen special sequence determination kit, plasminase-α2 fibrinase inhibitor complex determination kit, and tissue plasminogen activator-inhibitor 1 complex test kit, which are used for assisted diagnosis of osteoporosis, auxiliary diagnosis of thrombotic diseases, and auxiliary diagnosis of cardiovascular disease, respectively. As of the disclosure date of this announcement, the company and its holding subsidiaries have obtained 116 registration certificates for electrochemiluminescence supporting test reagents.